USA: Analytical Monitoring Tests Waters Develops Intelligent Fit-for-Purpose System
Editor: Alexander Stark
Waters Corporation has introduced the Bio Accord System. This purposefully designed liquid chromatography-mass spectrometry (LC-MS) solution is to expand access to high-resolution time-of-flight mass spectrometry capabilities to more scientists.
Waters Expands Accessibility to High Resolution MS Data with the First SmartMS-Enabled LC-MS Biopharma System
(Source: Business Wire)
Milford/USA — With this new system, the company promises to move routine monitoring out of centralized MS labs and into the hands of more scientists by enabling more effective analysis of biotherapeutic protein attributes across development and within quality control organizations.
As the monitoring requirements for biotherapeutics are growing exponentially, the inherent complexity of these therapies, combined with rising regulatory standards, are driving more intensive and widespread testing requirements, explains Chris O'Connell, Chairman and CEO, Waters Corporation. Waters designed the new system as a fit-for-purpose LC-MS biopharmaceutical solution to deliver rich mass spectrometry data for improved productivity and effective decision-making.
The Bio Accord System pairs Acquity UPLC I-Class Plus with the newly-developed Acquity RDa Detector featuring Smart MS. This system offers automated setup and self diagnosis through an intuitive user interface, all within a small footprint. Powered by Unifi, the compliance-ready LC-MS informatics platform, the Bio Accord System has been optimized for intact protein, released glycan, and peptide monitoring applications, and streamlined by the use of Waters' application-specific chemistries and consumables kits.
Unfold for details of your consent
Stand vom 23.03.2021
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.